Cybin Inc. Archives

Debra BorchardtNovember 15, 2023

After the markets closed on Tuesday, Cybin Inc. (NYSE: CYBN) (NEO: CYBN) reported unaudited financial results for its second quarter ended Sept. 30. Cybin reported a net loss of C$11.9 million for the quarter versus last year’s net loss of C$10 million. At present, Cybin’s operations do not generate cash flows and at the end of […]

Debra BorchardtOctober 25, 2023

Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the United States Patent and Trademark Office has issued two patent grants that offer protection for its deuterated N, N-dimethyltryptamine (“DMT“) program. “Following Cybin’s recent acquisition of Small Pharma Inc., our development programs are protected by 32 granted patents and over 170 pending applications, establishing our […]

Debra BorchardtOctober 18, 2023